Literature DB >> 16198426

Statistical analysis of data from studies on experimental autoimmune encephalomyelitis.

Kandace K Fleming1, James A Bovaird, Michael C Mosier, Mitchell R Emerson, Steven M LeVine, Janet G Marquis.   

Abstract

Research in multiple sclerosis often employs animal models of the disease, especially experimental autoimmune encephalomyelitis (EAE) in rodents. The statistical analysis procedures chosen for these studies are often suboptimal, either because of violations of the assumptions of the procedure or because the analysis selected is inappropriate for the research question. In this paper, we discuss the types of research questions frequently asked in EAE studies and suggest appropriate and useful research designs and statistical methods that will optimize the information contained within the data. We also discuss other troublesome issues such as missing data, atypical disease profiles, and power analysis.

Entities:  

Mesh:

Year:  2005        PMID: 16198426     DOI: 10.1016/j.jneuroim.2005.08.020

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  43 in total

1.  K/B×N serum transfer arthritis is delayed and less severe in leukaemia inhibitory factor (LIF)-deficient mice.

Authors:  A Upadhyay; D Senyschyn; L Santos; R Gu; G J Carroll; J A Jazayeri
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

2.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

3.  Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis.

Authors:  Niannian Ji; Animesh Somanaboeina; Aakanksha Dixit; Kazuyuki Kawamura; Neil J Hayward; Christopher Self; Gary L Olson; Thomas G Forsthuber
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

4.  Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis.

Authors:  Eric Blasko; Christopher A Haskell; Stewart Leung; Giovanna Gualtieri; Meredith Halks-Miller; Mithra Mahmoudi; Megan K Dennis; Eric R Prossnitz; William J Karpus; Richard Horuk
Journal:  J Neuroimmunol       Date:  2009-08-06       Impact factor: 3.478

5.  Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis.

Authors:  Brittany L Hartwell; Chad J Pickens; Martin Leon; Cory Berkland
Journal:  Biomacromolecules       Date:  2017-05-17       Impact factor: 6.988

6.  Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis.

Authors:  M Kelly Guyton; Arabinda Das; Supriti Samantaray; Gerald C Wallace; Jonathan T Butler; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-08-15       Impact factor: 4.164

7.  Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System.

Authors:  Stylianos Ravanidis; Kyriaki Nepheli Poulatsidou; Roza Lagoudaki; Olga Touloumi; Elena Polyzoidou; Athanasios Lourbopoulos; Evangelia Nousiopoulou; Paschalis Theotokis; Evangelia Kesidou; Dimitrios Tsalikakis; Dimitrios Karacostas; Maria Grigoriou; Katerina Chlichlia; Nikolaos Grigoriadis
Journal:  Stem Cells Transl Med       Date:  2015-10-28       Impact factor: 6.940

8.  Inhibition of calpain attenuates encephalitogenicity of MBP-specific T cells.

Authors:  Mary K Guyton; Saurav Brahmachari; Arabinda Das; Supriti Samantaray; Jun Inoue; Mitsuyoshi Azuma; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

9.  Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning.

Authors:  Richard E Jones; Nicole Moes; Heather Zwickey; Christopher L Cunningham; William L Gregory; Barry Oken
Journal:  Brain Behav Immun       Date:  2007-12-26       Impact factor: 7.217

10.  Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases.

Authors:  Michael S Donoviel; Nitai C Hait; Subramaniam Ramachandran; Michael Maceyka; Kazuaki Takabe; Sheldon Milstien; Tamas Oravecz; Sarah Spiegel
Journal:  FASEB J       Date:  2015-08-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.